
Organization (Industry)
ABIOMED, INC.
ClinicalTrials.gov lists ABIOMED, INC. as lead sponsor of 33 trials.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 1 registered with a 2026 start date. The dashed outline is the pace from the 1 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 4.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Logo ABIOMED, via Wikimedia Commons, Public domain. Shown to identify the organization; it may be a registered trademark.
This page covers ABIOMED, INC.: 33 lead-sponsored trials and 3 legal-entity registrations. Part of KENVUE INC..
Related companies are recorded in the same corporate group by GLEIF, ROR or a curator but are not grouped here; they are listed below with their own counts and are not included in the figures above.
Disease areas (25)
Shown in this order: most trials first (counted at this company's own legal-entity record, not the consolidated group).
| Disease area | Trials |
|---|---|
| Myocardial Infarction | 19 |
| Shock, Cardiogenic | 14 |
| Heart Failure | 12 |
| ST Elevation Myocardial Infarction | 6 |
| Non-ST Elevated Myocardial Infarction | 4 |
Showing 5 of 25 disease areas.
Trials by start year as sponsor or collaborator (18)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 3 |
| 2024 | 4 |
| 2023 | 5 |
| 2022 | 7 |
| 2021 | 4 |
| 2020 | 4 |
| 2019 | 3 |
| 2017 | 3 |
| 2016 | 1 |
Showing 10 of 18 years.
Prediction, not a registry value: median of 17 months from start to primary completion across 6 trials still running at the 2026-10-09 snapshot; registered median of 27 months across 16 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 55% hit target (n=11) | 50% on time (n=10) |
FDA inspection record (1)
| Latest classification | Inspections |
|---|---|
| OAI | 9 |
FDA recalls (79)
Shown in this order: most recent first.
| Product | Classification | Initiated |
|---|---|---|
| ABIOMED Impella RP Flex with SmartAssist Set, Pump Set Code 1000323, containing Kit, 23Fr Introducer, 11cm, Sterile, 23 Fr, 11 cm, Product Code 2000342. heart pump and accessories | Class I | 2026-06-11 |
| ABIOMED Impella CP Set, Pump Set Code 0048-0003, containing BIOMED Impella Introducer, 14 Fr, 13 cm & 25 cm, Product Code 0052-3046. heart pump and accessories | Class I | 2026-06-11 |
| ABIOMED Impella CP Introducer Kit 14 Fr, 13 and 25 cm, Pump Set Code 1000550, containing Kit, 14Fr Introducer, 13cm&25cm, Sterile, Introducer Product Code 0052-3046. heart pump and accessories | Class I | 2026-06-11 |
| ABIOMED Introducer Kit 23 Fr, 11 cm, Pump Set Code 1000441, containing Kit, 23Fr Introducer, 11cm, Sterile, Introducer Product Code 2000342. heart pump and accessories | Class I | 2026-06-11 |
| ABIOMED Impella CP Introducer Kit 14 Fr, 13 cm, Pump Set Code 0052-0038, containing Kit, 14Fr Introducer, 13cm, Long Taper, Introducer Product Code 0052-3052. heart pump and accessories | Class I | 2026-06-11 |
Showing 5 of 79 recalls.
Manufacturing and distribution sites (1)
| Facility | Location | Regulators | Member organization |
|---|---|---|---|
| ABIOMED, INC. | DANVERS, US | FDA |
CLIA clinical laboratory certificates (1)
| Lab | Certificate | Status |
|---|---|---|
| ABIOMED, INC | Certificate of waiver | Terminated |
Biomarker capability evidence (52)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| CPO | Trial collaborator | Named in trial inclusion criteria |
| CPOX | Trial collaborator | Named in trial inclusion criteria |
| DLD | Trial collaborator | Named in trial inclusion criteria |
| DLD | Trial sponsor | Named in trial inclusion criteria |
| DLD | Trial sponsor | Named in trial inclusion criteria |
Showing 5 of 52 evidence rows.
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, active development programs, approved assets, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda import refusals, climate targets, as filed, workforce and board diversity, as filed, and organization relationships.
Counted at group level under Johnson & Johnson: journals published in, us granted patents, latest dated events, and biomarkers this organization publishes on.